Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case report

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread across the globe, leading to the declaration of a pandemic. While most present mild symptoms, it appears as though nearly 20% of confirmed patients develop significant complications. At this time of uncertainty, we a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mounir, Louardi, Mehdi, Simou, Kawtar, Fahmaoui, Akram, Mansour, Youness, Et-tahir, Meryem, Tabat, Othmane, Joutey Tahiri, Imane, Elkhaouri, Hanane, Ezzouine, Boubakar, Charra, Marieme, Camara, Mouna, Lamchahab, Asmaa, Harrach, Asmaa, Quessar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796834/
https://www.ncbi.nlm.nih.gov/pubmed/33456658
http://dx.doi.org/10.11604/pamj.supp.2020.37.1.25501
_version_ 1783634763326685184
author Mounir, Louardi
Mehdi, Simou
Kawtar, Fahmaoui
Akram, Mansour
Youness, Et-tahir
Meryem, Tabat
Othmane, Joutey Tahiri
Imane, Elkhaouri
Hanane, Ezzouine
Boubakar, Charra
Marieme, Camara
Mouna, Lamchahab
Asmaa, Harrach
Asmaa, Quessar
author_facet Mounir, Louardi
Mehdi, Simou
Kawtar, Fahmaoui
Akram, Mansour
Youness, Et-tahir
Meryem, Tabat
Othmane, Joutey Tahiri
Imane, Elkhaouri
Hanane, Ezzouine
Boubakar, Charra
Marieme, Camara
Mouna, Lamchahab
Asmaa, Harrach
Asmaa, Quessar
author_sort Mounir, Louardi
collection PubMed
description The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread across the globe, leading to the declaration of a pandemic. While most present mild symptoms, it appears as though nearly 20% of confirmed patients develop significant complications. At this time of uncertainty, we are struggling to provide appropriate care to hematological cancer patients. We need to weigh the risks and benefits of giving cancer treatment against the odds of infecting them with COVID-19. As hematological cancer patients are immunocompromised and there are high chances of exposure during hospital visits, they can get infected and outcome can be fatal. So in this case report, we intend to discuss the possible impact of the current COVID-19 pandemic on patients with acute leukaemia in terms of diagnosis, chemotherapy, and prophylactic measures.
format Online
Article
Text
id pubmed-7796834
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The African Field Epidemiology Network
record_format MEDLINE/PubMed
spelling pubmed-77968342021-01-15 Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case report Mounir, Louardi Mehdi, Simou Kawtar, Fahmaoui Akram, Mansour Youness, Et-tahir Meryem, Tabat Othmane, Joutey Tahiri Imane, Elkhaouri Hanane, Ezzouine Boubakar, Charra Marieme, Camara Mouna, Lamchahab Asmaa, Harrach Asmaa, Quessar Pan Afr Med J Case Report The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread across the globe, leading to the declaration of a pandemic. While most present mild symptoms, it appears as though nearly 20% of confirmed patients develop significant complications. At this time of uncertainty, we are struggling to provide appropriate care to hematological cancer patients. We need to weigh the risks and benefits of giving cancer treatment against the odds of infecting them with COVID-19. As hematological cancer patients are immunocompromised and there are high chances of exposure during hospital visits, they can get infected and outcome can be fatal. So in this case report, we intend to discuss the possible impact of the current COVID-19 pandemic on patients with acute leukaemia in terms of diagnosis, chemotherapy, and prophylactic measures. The African Field Epidemiology Network 2020-11-11 /pmc/articles/PMC7796834/ /pubmed/33456658 http://dx.doi.org/10.11604/pamj.supp.2020.37.1.25501 Text en Copyright: Louardi Mounir et al. https://creativecommons.org/licenses/by/4.0/The Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Mounir, Louardi
Mehdi, Simou
Kawtar, Fahmaoui
Akram, Mansour
Youness, Et-tahir
Meryem, Tabat
Othmane, Joutey Tahiri
Imane, Elkhaouri
Hanane, Ezzouine
Boubakar, Charra
Marieme, Camara
Mouna, Lamchahab
Asmaa, Harrach
Asmaa, Quessar
Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case report
title Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case report
title_full Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case report
title_fullStr Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case report
title_full_unstemmed Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case report
title_short Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case report
title_sort severe covid-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796834/
https://www.ncbi.nlm.nih.gov/pubmed/33456658
http://dx.doi.org/10.11604/pamj.supp.2020.37.1.25501
work_keys_str_mv AT mounirlouardi severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport
AT mehdisimou severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport
AT kawtarfahmaoui severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport
AT akrammansour severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport
AT younessettahir severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport
AT meryemtabat severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport
AT othmanejouteytahiri severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport
AT imaneelkhaouri severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport
AT hananeezzouine severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport
AT boubakarcharra severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport
AT mariemecamara severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport
AT mounalamchahab severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport
AT asmaaharrach severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport
AT asmaaquessar severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport